Vyvanse and Visual impairment - a phase IV clinical study of FDA data
Summary:
Visual impairment is reported as a side effect among people who take Vyvanse (lisdexamfetamine dimesylate), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Prednisone, and have Narcolepsy.
The phase IV clinical study analyzes which people have Visual impairment when taking Vyvanse. It is created by eHealthMe based on reports of 28,083 people who have side effects when taking Vyvanse from the FDA, and is updated regularly.
What is Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,870 Vyvanse users. Check the latest studies of Vyvanse.
What is Visual impairment?
Visual impairment is found to be associated with 2,248 drugs and 2,336 conditions by eHealthMe. Check the latest studies of Visual impairment.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
28,083 people reported to have side effects when taking Vyvanse.
Among them, 231 people (0.82%) have Visual impairment.
Among these 231 people:
How long have people been on Vyvanse when they have Visual impairment? *
What is the gender of people who have Visual impairment when taking Vyvanse? *
What is the age of people who have Visual impairment when taking Vyvanse? *
What are other drugs people take besides Vyvanse? *
What are other side effects people have besides Visual impairment? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Vyvanse and have Visual impairment?
- Check whether Visual impairment is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Vyvanse:
- Vyvanse (35,870 reports)
Visual impairment treatments and more:
- Visual impairment (128,338 reports)
How severe was Visual impairment and when was it recovered:
Expand to all the drugs that have ingredients of lisdexamfetamine dimesylate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Visual impairment:
- Visual impairment (2,248 drugs)
Browse all the conditions that are associated with Visual impairment:
- Visual impairment (2,336 conditions)
Related publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on lisdexamfetamine dimesylate (the active ingredients of Vyvanse) and Vyvanse (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Megestrol Acetate and Neulasta drug interactions for women aged 60+ - 3 seconds ago
- Total Lung Capacity Decreased and drugs of ingredients of diltiazem hydrochloride - 3 seconds ago
- Could Zometa cause Astigmatism? - 3 seconds ago
- Drug interactions of Sudafed 12 Hour and Mucinex - 5 seconds ago
- High Blood Pressure and Angioneurotic Oedema - 5 seconds ago
- Etoposide and Shock - Anaphylactic for Men aged 50-59 - 10 seconds ago
- Etoposide and Anaphylactic Shock for Men aged 50-59 - 10 seconds ago
- Etoposide and Anaphylactic Reaction for Men aged 50-59 - 10 seconds ago
- Etoposide and Anaphylaxis for Men aged 50-59 - 11 seconds ago
- Could Amoxicillin cause Water Intoxication? - 11 seconds ago